Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $4.4 million.

  • Organogenesis Holdings' Short-term Investments rose 64488.05% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 64488.05%. This contributed to the annual value of $580000.0 for FY2024, which is 1646.59% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Short-term Investments stood at $4.4 million, which was up 64488.05% from $5.3 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Short-term Investments peaked at $7.0 million during Q1 2025, and registered a low of $487000.0 during Q3 2021.
  • Moreover, its 5-year median value for Short-term Investments was $599000.0 (2021), whereas its average is $1.4 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first tumbled by 3867.0% in 2023, then surged by 87680.56% in 2025.
  • Over the past 5 years, Organogenesis Holdings' Short-term Investments (Quarter) stood at $599000.0 in 2021, then surged by 35.56% to $812000.0 in 2022, then crashed by 38.67% to $498000.0 in 2023, then rose by 16.47% to $580000.0 in 2024, then skyrocketed by 652.59% to $4.4 million in 2025.
  • Its last three reported values are $4.4 million in Q3 2025, $5.3 million for Q2 2025, and $7.0 million during Q1 2025.